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ABSTRACT
Aims/Introduction: Abnormalities in Ca2+ signaling have a key role in hemodynamic
dysfunction in diabetic heart. The purpose of this study was to explore the effects of
streptozotocin (STZ)-induced diabetes on Ca2+ signaling in epicardial (EPI) and endocardial
(ENDO) cells of the left ventricle after 5–6 months of STZ injection.
Materials and Methods: Whole-cell patch clamp was used to measure the L-type
Ca2+ channel (LTCC) and Na+/Ca2+ exchanger currents. Fluorescence photometry techniques were used to measure intracellular free Ca2+ concentration.
Results: Although the LTCC current was not significantly altered, the amplitude of Ca2+
transients increased significantly in EPI-STZ and ENDO-STZ compared with controls. Time
to peak LTCC current, time to peak Ca2+ transient, time to half decay of LTCC current and
time to half decay of Ca2+ transients were not significantly changed in EPI-STZ and
ENDO-STZ myocytes compared with controls. The Na+/Ca2+ exchanger current was significantly smaller in EPI-STZ and in ENDO-STZ compared with controls.
Conclusions: STZ-induced diabetes resulted in an increase in amplitude of Ca2+ transients in EPI and ENDO myocytes that was independent of the LTCC current. Such an
effect can be attributed, at least in part, to the dysfunction of the Na+/Ca2+ exchanger.
Additional studies are warranted to improve our understanding of the regional impact of
diabetes on Ca2+ signaling, which will facilitate the discovery of new targeted treatments
for diabetic cardiomyopathy.

INTRODUCTION
Cardiac contractility is controlled by variations in the concentration of intracellular free Ca2+. During the process of excitation–
contraction coupling, depolarization of the ventricular myocyte
causes the opening of L-type Ca2+ channel (LTCCs) and the
inﬂux of small amounts of Ca2+ into the cardiac cells. This inﬂux
of Ca2+ stimulates a large release of Ca2+ (Ca2+ transient) from
the sarcoplasmic reticulum (SR) through the ryanodine receptors
(RyR) resulting in a transient rise of intracellular Ca2+ (Ca2+ transient). Ca2+ attaches to troponin C, which initiates and regulates
the process of myocyte contraction. During the process of
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myocyte relaxation, Ca2+ is removed from the cytoplasm through
four main pathways: (i) the uptake of Ca2+ into the SR through
SR Ca2+-ATPase (SERCA pump); (ii) efﬂux of Ca2+ from the cell
primarily through the Na+/Ca2+ exchanger (NCX); and (iii) to a
lesser extent the Ca2+-ATPase in the plasma membrane1; and (iv)
also uptake of Ca2+ by the mitochondria2,3.
Disturbances in the mechanism(s) of Ca2+ signaling will
inevitably have implications for cardiac myocyte contraction.
Previous studies of left ventricle cells obtained from the STZtreated rat have shown alterations in the Ca2+ transient, including prolonged TPK4,5, prolonged THALF relaxation6 and unaltered7 or reduced8 amplitude of Ca2+ transient. These
alterations in Ca2+ transient might be attributed variously to
diminished SR Ca2+ content, release and uptake9–11, reduced
activity of L-type Ca2+ channel12–14 and NCX7,13.
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Supporting these ﬁndings, earlier studies of STZ-treated rats
variously reported reduced cardiac output, fractional shortening
and ejection fraction4,14,15. In cardiac cells isolated from STZtreated rat, there was a prolonged time course of shortening6,16,17, frequently prolonged relaxation4,16, and slowed velocity of shortening and re-lengthening14. Studies also showed
either no signiﬁcant change6,12 or reduction14 in the amplitude
of shortening. These different results could be partly attributed
to the duration of diabetes or the methodology used in the
experiments.
It is well known that the electromechanical characteristics of
cardiac cells across the ventricular walls are different. This
heterogeneity is partly attributed to distinctive expression of different ion channels and associated ionic currents that lead to
variation in action potential waveforms seen in epicardial (EPI),
midmyocardial and endocardial (ENDO) cells18–20. For example, in vivo echocardiographic studies in rat ventricular myocardium have shown that layers of the epicardium contract less
and slower than the layers of the subendocardium21. It is
important to highlight that any disruption in the differential
distribution of ion channels responsible for Ca2+ transport
across the walls of the ventricles is expected to be involved in
the dysfunction of cardiac cells in disease7,15,22,23. Earlier work
in spontaneously hypertensive rats has shown a transmurally
altered time course and amplitude of action potential, variation
in Ca2+ transients, and contraction in sub-EPI and sub-ENDO
myocytes during compensated hypertrophy24. Transmural alteration in the activity of NCX, Ca2+ content of the SR and amplitude of Ca2+ transient have also been shown in an earlier study
in spontaneously hypertensive rat25.
To date, only a few studies have explored the transmural
effect of STZ-induced diabetes on Ca2+ signaling in ventricular
myocytes26–28. For this reason, the current work was undertaken to investigate the progressive regional effects of diabetes
on ventricular myocytes. To the best of our knowledge, this is
the ﬁrst study to investigate the effects of STZ-induced diabetes
on LTCC current simultaneously measured with Ca2+ transients. Previous experiments generally measured LTCC current
and Ca2+ transient in separate experiments. The inﬂux of Ca2+
through LTCCs is inextricably linked to the release of Ca2+
from the SR (Ca2+-induced Ca2+ release). Therefore, this study
has investigated the effects of STZ-induced diabetes on LTCC
current simultaneously measured with intracellular Ca2+, and
also NCX current in EPI and ENDO ventricular myocytes from
rats 5–6 months after the induction of diabetes.

METHODS
Experimental model

Experiments were carried out in STZ-induced diabetic rats29,30.
A single intraperitoneal injection of STZ (60 mg/kg bodyweight) in citrate buffer was used to induce diabetes in young
adult (220–250 g) male Wistar rats. Age-matched control animals were injected with citrate buffer alone. Rats were kept in a
12/12 h light/dark cycle. Food and water were supplied
2
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ad libitum. Both the control and experimental groups received
standard pelleted rat chow.
Before each experiment, body and heart weights, in addition
to non-fasting blood glucose level (One Touch Ultra, LifeScan
Inc., Milpitas, CA, USA) were measured. All experiments were
carried out 5–6 months after treatment with STZ in ENDO
and EPI myocytes. Ethical approval of the work was received
from the UAE University Animal Research Ethics Committee
(UAE University, A11-15, 2015). All experiments were carried
out according to the institution guidelines.
Isolation of ventricular myocytes

Ventricular myocytes were obtained by enzymatic and mechanical dispersal techniques in accordance with previously
described protocols24,27,28. Animals were euthanized with a guillotine. Hearts were isolated, mounted on a Langendorff system
for retrograde perfusion and perfused at 36–37°C with a cell
isolation solution (see Appendix S1)27. The perfusion ﬂow rate
was 8 mL/g heart-1min-1. On stabilization of heart contraction,
perfusion was switched to Ca2+-free cell isolation solution containing egtazic acid (0.1 mmol/L) for 4 min, and then to cell
isolation solution containing Ca2+ (0.05 mmol/L), type 1 collagenase (0.60 mg/mL) and type XIV protease (0.075 mg/mL)
for 6 min. On completion of enzymatic treatment, hearts were
detached from the Langendorff perfusion system and the left
ventricle was further dissected as described in earlier studies27,28. Thin sections were carefully dissected by ﬁne scissors
from the outermost layer (EPI) and innermost layer (ENDO)
of the left ventricle. The sections were gently minced and shaken in an isolation solution containing collagenase and 1%
bovine serum albumin. Cells were then ﬁltered at 4-min intervals and re-suspended in cell isolation solution that contained
0.75 mmol/L Ca2+.
Simultaneous recording of L-type Ca2+ current and Ca2+
transient

Simultaneous recording of LTCC current and Ca2+ transients
were measured in EPI and ENDO ventricular cells according to
modiﬁcations of previously described methods27,28,31. All experiments were carried out at 34°C. LTCC current was measured
with an Axopatch 200B ampliﬁer (Molecular Devices, Sunnyvale, CA, USA). Analog signal was ﬁltered using a four-pole
Bessel ﬁlter (bandwidth of 5 kHz), and digitized at a sampling
rate of 10 kHz using a Digidata 1550 digitizer (Molecular
Devices). The voltage clamp protocols and data acquisition
were controlled by WinWCP 4.05 software (Strathclyde Electrophysiology Software, Glasgow, UK). Patch pipettes were
made from ﬁlamented borosilicate glass. Resistance of electrodes
was 2–4 MΩ. Seal resistances were 1–5 GΩ. A current–voltage
(I-V) relationship was achieved by the application of 300 ms
test pulses (-30 to +50 mV) in 10 mV steps from a holding
potential of -40 mV. Intracellular Ca2+ recordings were
obtained by loading the cells with 30 lmol/L fura-2-pentapotassium salt through the patch pipette for 5 min, and
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The NCX current was recorded according to modiﬁcations of
previously described techniques31. Experiments were carried
out at 34°C. Recording of the NCX current was obtained with
an Axopatch 200B ampliﬁer using a voltage ramp protocol.
Cells were held at a holding potential of -40 mV. Voltage
ramps were deployed at a steady rate of 0.1 V/s from
+60 mV to -100 mV. Resistance of electrodes was 3–5 MΩ.
Seal resistances were 1–5 GΩ. Oubain (100 lmol/L), nifedipine
(10 lmol/L) and niﬂumic acid (30 lmol/L) were used to
block Na+-K+-ATPase, Ca2+ and Cl- currents, respectively.
Nickel chloride solution (10 mmol/L) was used to block NCX.
The NCX current was measured as the current sensitive to
nickel (Ni2+). NCX current was isolated by subtracting Ni2+insensitive component from the total current31. Whole-cell
bath solution and pipette solution used are described in
Appendix S1.
Statistical analysis

Results were represented as mean – standard error of the men
of “n” observations. As appropriate, independent samples t-test
or one-way ANOVA followed by Bonferroni corrected t-tests were
used for statistical comparisons. A P-value <0.05 was considered signiﬁcant.

RESULTS
General characteristics

Bodyweight and heart weight were signiﬁcantly reduced
(P < 0.05) in STZ-pretreated diabetic rats. In comparison with
their respective age-matched controls, heart weight/bodyweight
Table 1 | General characteristics of streptozotocin-induced diabetic and
age-matched control rats

Bodyweight (g)
Heart weight (g)
Heart weight/bodyweight (mg/g)
Non-fasting blood glucose (mg/dL)

CONTROL
STZ

250

Capacitance (pF)

excited at 360- and 380-nm wavelengths with dual LED light
source, controlled by a spectrophotometry unit at 100 Hz. The
ﬂuorescence signal at 510 nm was collected through an adjustable diaphragm and a photomultiplier tube. WinWCP 4.05 software was used to sample signals at 10 kHz. All data were
stored on a computer for subsequent analysis. After the subtraction of background signal, ﬂuorescent signals were recorded
as F360/F380 (ratio of the ﬂuorescent intensity when excited at
360 nm [F360] to that when excited at 380 nm [F380] and
expressed as a ratio unit). The whole-cell bath solution and pipette solution used are described in the Appendix S1.

Control

Streptozotocin

417.3 – 9.9
1.45 – 0.03
3.50 – 0.07
83.3 – 1.31

274.2 – 8.6†
1.28 – 0.03†
4.68 – 0.10†
483.9 – 20.2†

Data are the mean – standard error of the mean, n = 15–17 rats.
†
P < 0.05 for diabetic compared with controls.
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Figure 1 | Mean cell capacitance in endocardial control (ENDO-CON),
endocardial streptozotocin (STZ)-pretreated (ENDO-STZ), epicardial
control (EPI-CON) and epicardial streptozotocin-pretreated (EPI-STZ)
myocytes. Data are the mean – standard error of the mean, n = 13–17
cells from 10–14 hearts; *P < 0.05.

and non-fasting blood glucose were greater in STZ-pretreated
diabetic rats (Table 1).
Cell capacitance

Cell capacitance was signiﬁcantly lower in ENDO-STZ compared with ENDO-CON ventricular cells (P < 0.05; Figure 1).
There was a small variation in cell capacitance between EPISTZ and EPI-CON myocytes; however, the variation was not
signiﬁcant (P > 0.05).
L-type Ca2+ current and Ca2+ transient

Typical tracings of LTCC current and Ca2+ transients measured at 0 mV test potential are shown in Figure 2a. The
mean current–voltage (I/V) relationships of the LTCC current
for ENDO-STZ, ENDO-CON, EPI-STZ and EPI-CON ventricular cells are shown in Figure 2b, and the currents generated at 0 mV test voltage are represented in Figure 2c. LTCC
current amplitudes were not signiﬁcantly (P > 0.05) different
in ENDO-STZ and EPI-STZ compared with their respective
controls at 0 mV (Figure 2c). Ca2+ transient fura-2 ratio-voltage relationship for ENDO-STZ, ENDO-CON, EPI-STZ and
EPI-CON ventricular myocytes are represented in Figure 2d.
Ca2+ transients generated at 0 mV are represented in Figure 2e. The amplitude of Ca2+ transients were signiﬁcantly
(P < 0.05) larger in ENDO-STZ and EPI-STZ compared with
their controls (Figure 2e). TPK LTCC current (Figure 2f) and
TPK Ca2+ transient (Figure 2g) were not signiﬁcantly
(P > 0.05) different in ENDO-STZ and EPI-STZ compared
with their respective controls (P > 0.05). THALF decay of
LTCC current (Figure 2h) and THALF decay of the Ca2+
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Figure 2 | L-type Ca2+ channel (LTCC) current and Ca2+ transient in endocardial control (ENDO-CON), endocardial streptozotocin (STZ)-pretreated
(ENDO-STZ), epicardial control (EPI-CON) and epicardial streptozotocin-pretreated (EPI-STZ) myocytes. (a) Typical recordings of LTCC current and
Ca2+ transient at a test potential of 0 mV. (b) Mean recordings of LTCC current at test voltages in the range -30 to +50 mV. (c) Mean LTCC
current at a test voltage of 0 mV. (d) Mean recordings of amplitude (AMP) of Ca2+ transients at test voltages in the range -30 to +50 mV. (e)
Mean AMP of Ca2+ transients at a test potential of 0 mV. (f) TPK of LTCC current at test potentials in the range -30 to +50 mV. (g) TPK of Ca2+
transients at test potentials in the range -30 to +50 mmol/L. (h) Time to half decay of LTCC current at test potentials in the range -30 to +50 mV.
(i) Time to half of Ca2+ transients at test potentials in the range -30 to +50 mV. Data are the mean – standard error of the mean, n = 13–16 cells
from 12–14 hearts; *P < 0.05.

transient (Figure 2i) were not signiﬁcantly (P < 0.05) different
in ENDO-STZ and EPI-STZ compared with their respective
controls.

100 mV, the amplitude of the NCX current was signiﬁcantly
(P < 0.05) smaller in ENDO-STZ and EPI-STZ compared with
their respective controls (Figure 3c).

Na+/Ca2+ exchange current

DISCUSSION
The ﬁndings of the present study show that STZ-induced
diabetes causes signiﬁcant alteration in Ca2+ transients and
NCX current in EPI and ENDO ventricular myocytes. To
the best of our knowledge, this is the ﬁrst study to investigate the regional effects of STZ-induced diabetes on LTCC
current simultaneously measured with Ca2+ transients and
NCX current in ventricular myocytes from STZ-induced diabetic rat.
Many changes during excitation–contraction coupling might
give rise to changes in the Ca2+ transient. In our experiments,

The current of NCX was recorded by applying a voltage ramp
between +60 and -100 mV. The NCX current was calculated
as the difference between the current generated in the presence
of 10 µmol/L nifedipine and the current in the presence of
nifedipine and 10 mmol/L Ni2+. Mean recordings of the ramp
current in ENDO-CON, ENDO-STZ, EPI-CON and EPI-STZ
ventricular cells are represented in Figure 3a. At +60 mV, the
amplitude of the NCX current was signiﬁcantly (P < 0.05)
smaller in ENDO-STZ and in EPI-STZ compared with their
respective controls (P < 0.05) (Figure 3b). Similarly, at 4
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Figure 3 | Na+/Ca2+ exchange current in endocardial control (ENDO-CON), endocardial streptozotocin (STZ)-pretreated (ENDO-STZ), epicardial
control (EPI-CON) and epicardial streptozotocin-pretreated (EPI-STZ) myocytes. (a) Mean recordings of Na+/Ca2+ exchange current in (range –100 to
+60 mV). (b) Mean peak currents of Na+/Ca2+ exchange current at +60 mV. (c) Mean peak currents of Na+/Ca2+ exchange current at -100 mV.
Data are the mean – standard error of the mean, n = 14–17 cells from 9–11 hearts. *P < 0.05. NCX, Na+/Ca2+ exchanger.

the amplitude and the kinetics of the LTCC current were similar in rat ventricular cells from EPI compared with ENDO
regions. The amplitude of LTCC currents were not signiﬁcantly
different in ENDO-STZ and EPI-STZ ventricular cells compared with their controls. Although some studies have previously reported decreased amplitude12,32, many studies have
reported no change in LTCC currents in ventricular cells from
STZ-treated rat4,11,33,34.
Interestingly, the amplitude of the Ca2+ transients were significantly larger in EPI-STZ and ENDO-STZ myocytes compared
with their respective controls. However, no regional difference
in Ca2+ transients was observed. Earlier studies reported either
reduced4,15,35 or unaltered16,32,36 Ca2+ transients in ventricular
cells, isolated from STZ-induced diabetic animals. In comparison with other studies, in which Ca2+ transients were measured
after 3–12 weeks of STZ treatment16,17,32,33,37, the present experiments were carried out in EPI and ENDO ventricular myocytes
5–6 months after STZ treatment. Thus, the variation in results

ª 2020 The Authors. Journal of Diabetes Investigation published by AASD and John Wiley & Sons Australia, Ltd

might be partly related to the degree of progression of diabetes.
Furthermore, the discrepancy between the present data and
other results, where decreased amplitude38 or no change in
amplitude7 of the Ca2+ transients were observed, might be
down to the fact that different Ca2+ dyes were used for intracellular Ca2+ recordings. In the present study, a low concentration
of fura-2-pentapotassium salt was dialyzed into the cell through
the patch pipette. However, other studies7,38 used ester of Indo1 to load the indicator. Although both are high afﬁnity indicators that have been used for cytosolic Ca2+ measurements in
many studies in cardiac myocytes and other cell types, variation
in indicator and/or loading technique might account for different results. For example, the use of ester of Indo-1 dye is sometimes associated with overloading of cytoplasm with Ca2+
indicator leading to increased buffering of Ca2+, slowing down
the transients’ decay and reducing their amplitude.
The observed rise in the amplitudes of Ca2+ transients is
explained by changes in pathways of Ca2+ extrusion (e.g.,
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NCX) which, along with SERCA, are responsible for decreasing
cytosolic Ca2+. In the present study, there was a signiﬁcant
decrease in NCX current in both EPI and ENDO ventricular
cells, although no regional difference in the activity of NCX
was observed. Earlier studies have also shown that the density
of NCX current was reduced7,13,39 and current inactivation was
prolonged13 in ventricular cells isolated from STZ-treated diabetic rats. These variations in the amplitude and kinetics of current were accompanied with decreased NCX messenger
ribonucleic acid (mRNA)7 and reduced or unaltered NCX protein in STZ-induced diabetic rat heart8,11,40. It is possible that
the decrease in the Ca2+ extrusion rate through NCX leads to a
net increase in intracellular Ca2+41, increase in SR Ca2+ load
and, as a consequence, increased cytosolic Ca2+ transients11,14,17,33,42. Alternatively, the increase in the amplitude of
Ca2+ transients can be linked to RyR dysfunction. Abnormal
function of RyR is associated with various diseases, including
cardiac hypertrophy and STZ-induced type 1 diabetes43. It is
known that the metabolic changes associated with diabetes
stimulate the production of reactive oxygen species. As RyR
structure is rich in free thiol groups, it is subject to oxidative
stress, changing its tertiary structure and altering its sensitivity
to Ca2+43,44. In an earlier study in 7-week sedentary type 1 diabetic rats, the frequency of Ca2+ spark was threefold higher,
and evoked release of Ca2+ was dys-synchronous with the diastolic release. Although the steady-state RyR protein was not
altered, its response to Ca2+ was changed. The RyR also showed
an approximately 1.5-fold rise in phosphorylation at Ser 2808
and Ser 2814 residues14.
In addition to the effects observed in diabetes, earlier studies
have shown that hypertension-induced cardiac hypertrophy
causes an alteration in the amplitude and the time course of
systolic Ca2+ transients. Fowler et al.25 showed that NCX activity is diminished, whereas the amplitude of Ca2+ transient and
SR Ca2+ content are increased in spontaneously hypertensive
rats in comparison with their respective controls. It was suggested that alteration in Ca2+ signaling during compensated
hypertrophy is attributed to the reduction in ventricular myocyte NCX activity. As a result, SR Ca2+ content increases and
thus, the Ca2+ transient amplitude, serving to maintain the
force of contraction against the elevated afterload25,45. This
observation is consistent with the increased SR Ca2+ content of
spontaneously hypertensive rat ventricular cells reported previously46. Similarly, an increase in SR Ca2+ content, SR Ca2+
release and amplitude of Ca2+ transients were also described in
a canine model of compensated hypertrophy that was induced
by chronic atrioventricular block47.
Earlier studies have also reported that abnormal intracellular
Ca2+ transport is caused by the change in expression of proteins that modulate intracellular Ca2+. For example, Teshima
et al.23 showed that expression of SERCA and RyR mRNA
were signiﬁcantly altered in the heart, 3 and 12 weeks postSTZ injection, respectively. Hattori et al.7 showed that the
reduction in cardiac NCX activity is due to the reduction in
6

J Diabetes Investig Vol.  No.   2020

http://wileyonlinelibrary.com/journal/jdi

NCX mRNA and protein 6 weeks after the induction of diabetes with STZ. Changes in the expression of mRNA that
encodes different proteins in cardiac muscle have also been previously reported in data from our laboratory48.
Transmural gradients in myocyte Ca2+ handling proteins
exist across the ventricular wall. For example, it has been
shown that Ca2+ handling proteins, such as SERCA, RyR and
NCX, are more abundant in the EPI cells than ENDO cells in
various species49–51. The results of the present study showed
that the amplitude of the NCX current is larger in EPI-CON
compared with END-CON. Supporting this ﬁnding, Xiong
et al.51 reported that the NCX current, protein and mRNA
were greater in EPI than ENDO or midmyocardial cells. Wang
et al.20 also reported the transmural gradient in NCX with the
capacity for Ca2+ extrusion by NCX being ENDO < midmyocardial < EPI. The spatial electrical heterogeneity of ion channels and proteins has a profound effect not only on normal
cardiac electrophysiology and contractility, but also on the genesis of cardiac arrhythmias in diseased hearts. For example, the
loss of this non-uniformity has been previously reported to be
a sensitive index to discriminate physiological from pathological left ventricular remodeling21. The diminished NCX function
in diabetic myocytes shown in the present study suggest that
NCX function might play an important role when Ca2+ rises
to pathological levels, such as in diabetic cardiomyopathy. Furthermore, the disruption of the transmural NCX gradient in
diabetic heart highlights a potential substrate for the production of lethal arrhythmias leading to heart failure in diabetes
patients.
In conclusion, the present study suggests that STZ-induced
diabetes causes a signiﬁcant rise in Ca2+ transient amplitudes
5–6 weeks after the induction of diabetes with a single
intraperitoneal injection of STZ. This change probably stems
partly from the dysfunction of NCX. Additional studies would
be required to further our understanding of how diabetes alters
Ca2+ handling in different regions of the heart. This will contribute to the development of new and regionally targeted treatments for diabetic cardiomyopathy.

ACKNOWLEDGMENTS
The work was funded by the College of Medicine and Health
Sciences, UAE University in Al Ain; Zayed University in Abu
Dhabi; and Al Ain Equestrian, Shooting and Golf Club.
DISCLOSURE
The authors declare no conﬂict of interest.
REFERENCES
1. Eisner DA, Caldwell JL, Kistamas K, et al. Calcium and
excitation-contraction coupling in the heart. Circ Res 2017;
121: 181–195.
2. Bodi I, Mikala G, Koch SE, et al. The L-type calcium channel
in the heart: the beat goes on. J Clin Investig 2005; 115:
3306–3317.

ª 2020 The Authors. Journal of Diabetes Investigation published by AASD and John Wiley & Sons Australia, Ltd

http://wileyonlinelibrary.com/journal/jdi

3. Walsh C, Barrow S, Voronina S, et al. Modulation of calcium
signalling by mitochondria. Biochim Biophys Acta 2009; 1787:
1374–1382.
4. Shao CH, Rozanski GJ, Patel KP, et al. Dyssynchronous (nonuniform) Ca2+ release in myocytes from streptozotocininduced diabetic rats. J Mol Cell Cardiol 2007; 42: 234–246.
5. Howarth FC, Almugaddum FA, Qureshi MA, et al. The
effects of heavy long-term exercise on ventricular myocyte
shortening and intracellular Ca2+ in streptozotocin-induced
diabetic rat. J Diabetes Complications 2010; 24: 278–285.
6. Ren J, Walsh MF, Hamaty M, et al. Altered inotropic
response to IGF-I in diabetic rat heart: influence of
intracellular Ca2+ and NO. Am J Physiol 1998; 275: H823–
H830.
7. Hattori Y, Matsuda N, Kimura J, et al. Diminished function
and expression of the cardiac Na+-Ca2+ exchanger in
diabetic rats: implication in Ca2+ overload. J Physiol 2000;
527(Pt 1): 85–94.
8. Lee TI, Chen YC, Kao YH, et al. Rosiglitazone induces
arrhythmogenesis in diabetic hypertensive rats with calcium
handling alteration. Int J Cardiol 2013; 165: 299–307.
9. Lagadic-Gossmann D, Buckler KJ, Le Prigent K, et al. Altered
Ca2+ handling in ventricular myocytes isolated from
diabetic rats. Am J Physiol 1996; 270(5 Pt 2): H1529–H1537.
10. Takeda N, Dixon IM, Hata T, et al. Sequence of alterations in
subcellular organelles during the development of heart
dysfunction in diabetes. Diabetes Res Clin Pract 1996; 30
(Suppl): 113–122.
11. Choi KM, Zhong Y, Hoit BD, et al. Defective intracellular Ca
(2+) signaling contributes to cardiomyopathy in Type 1
diabetic rats. Am J Physiol Heart Circ Physiol 2002; 283:
H1398–H1408.
12. Hamouda NN, Sydorenko V, Qureshi MA, et al. Dapagliflozin
reduces the amplitude of shortening and Ca(2+) transient
in ventricular myocytes from streptozotocin-induced
diabetic rats. Mol Cell Biochem 2015; 400: 57–68.
13. Chattou S, Diacono J, Feuvray D. Decrease in sodiumcalcium exchange and calcium currents in diabetic rat
ventricular myocytes. Acta Physiol Scand 1999; 166: 137–144.
14. Shao CH, Wehrens XH, Wyatt TA, et al. Exercise training
during diabetes attenuates cardiac ryanodine receptor
dysregulation. J Appl Physiol 1985; 2009: 1280–1292.
15. Tian C, Shao CH, Moore CJ, et al. Gain of function of cardiac
ryanodine receptor in a rat model of type 1 diabetes.
Cardiovasc Res 2011; 91: 300–309.
16. Rithalia A, Qureshi MA, Howarth FC, et al. Effects of
halothane on contraction and intracellular calcium in
ventricular myocytes from streptozotocin-induced diabetic
rats. Br J Anaesth 2004; 92: 246–253.
17. Howarth FC, Qureshi MA. Effects of carbenoxolone on heart
rhythm, contractility and intracellular calcium in
streptozotocin-induced diabetic rat. Mol Cell Biochem 2006;
289: 21–29.

ª 2020 The Authors. Journal of Diabetes Investigation published by AASD and John Wiley & Sons Australia, Ltd

ORIGINAL ARTICLE
Calcium transport in the diabetic heart

18. Remme CA, Verkerk AO, Hoogaars WM, et al. The cardiac
sodium channel displays differential distribution in the
conduction system and transmural heterogeneity in the
murine ventricular myocardium. Basic Res Cardiol 2009; 104:
511–522.
19. Abd Allah ES, Aslanidi OV, Tellez JO, et al. Postnatal
development of transmural gradients in expression of ion
channels and Ca2⁺-handling proteins in the ventricle. J Mol
Cell Cardiol 2012; 53: 145–155.
20. Wang W, Gao J, Entcheva E, et al. A transmural gradient in
the cardiac Na/K pump generates a transmural gradient in
Na/Ca exchange. J Membr Biol 2010; 233: 51–62.
21. A€ıt Mou Y, Reboul C, Andre L, et al. Late exercise training
improves non-uniformity of transmural myocardial function
in rats with ischaemic heart failure. Cardiovasc Res 2009; 81:
555–564.
22. Lu Z, Jiang YP, Xu XH, et al. Decreased L-type Ca2+ current
in cardiac myocytes of type 1 diabetic Akita mice due to
reduced phosphatidylinositol 3-kinase signaling. Diabetes
2007; 56: 2780–2789.
23. Teshima Y, Takahashi N, Saikawa T, et al. Diminished
expression of sarcoplasmic reticulum Ca(2+)-ATPase and
ryanodine sensitive Ca(2+)Channel mRNA in streptozotocininduced diabetic rat heart. J Mol Cell Cardiol 2000; 32: 655–
664.
24. McCrossan ZA, Billeter R, White E. Transmural changes in
size, contractile and electrical properties of SHR left
ventricular myocytes during compensated hypertrophy.
Cardiovasc Res 2004; 63: 283–292.
25. Fowler MR, Naz JR, Graham MD, et al. Decreased Ca2+
extrusion via Na+/Ca2+ exchange in epicardial left
ventricular myocytes during compensated hypertrophy. Am
J Physiol Heart Circ Physiol 2005; 288: H2431–H2438.
26. Casis O, Gallego M, Iriarte M, et al. Effects of diabetic
cardiomyopathy on regional electrophysiologic
characteristics of rat ventricle. Diabetologia 2000; 43: 101–
109.
27. Smail MM, Qureshi MA, Shmygol A, et al. Regional effects of
streptozotocin-induced diabetes on shortening and calcium
transport in epicardial and endocardial myocytes from rat
left ventricle. Physiol Rep 2016; 4: e13034.
28. Al Kury L, Sydorenko V, Smail MMA, et al. Voltage
dependence of the Ca(2+) transient in endocardial and
epicardial myocytes from the left ventricle of Goto-Kakizaki
type 2 diabetic rats. Mol Cell Biochem 2018; 446: 25–33.
29. Szkudelski T. Streptozotocin-nicotinamide-induced diabetes
in the rat. Characteristics of the experimental model. Exp
Biol Med 2012; 237: 481–490.
30. Cheta D. Animal models of type I (insulin-dependent)
diabetes mellitus. J Pediatr Endocrinol Metab 1998; 11: 11–19.
31. Al Kury LT, Yang KH, Thayyullathil FT, et al. Effects of
endogenous cannabinoid anandamide on cardiac Na(+)/Ca
(2)(+) exchanger. Cell Calcium 2014; 55: 231–237.

J Diabetes Investig Vol.  No.   2020

7

ORIGINAL ARTICLE
Al Kury et al.

32. Bracken N, Howarth FC, Singh J. Effects of streptozotocininduced diabetes on contraction and calcium transport in
rat ventricular cardiomyocytes. Ann N Y Acad Sci 2006; 1084:
208–222.
33. Yaras N, Ugur M, Ozdemir S, et al. Effects of diabetes on
ryanodine receptor Ca release channel (RyR2) and Ca2+
homeostasis in rat heart. Diabetes 2005; 54: 3082–3088.
34. Arikawa M, Takahashi N, Kira T, et al. Enhanced inhibition of
L-type calcium currents by troglitazone in streptozotocininduced diabetic rat cardiac ventricular myocytes. Br J
Pharmacol 2002; 136: 803–810.
35. Moore CJ, Shao CH, Nagai R, et al. Malondialdehyde and 4hydroxynonenal adducts are not formed on cardiac
ryanodine receptor (RyR2) and sarco(endo)plasmic reticulum
Ca2+-ATPase (SERCA2) in diabetes. Mol Cell Biochem 2013;
376: 121–135.
36. Hamouda NN, Qureshi MA, Alkaabi JM, et al. Reduction in
the amplitude of shortening and Ca(2+) transient by
phlorizin and quercetin-3-O-glucoside in ventricular
myocytes from streptozotocin-induced diabetic rats. Physiol
Res 2016; 65: 239–250.
37. Yaras N, Bilginoglu A, Vassort G, et al. Restoration of
diabetes-induced abnormal local Ca2+ release in
cardiomyocytes by angiotensin II receptor blockade. Am J
Physiol Heart Circ Physiol 2007; 292: H912–H920.
38. Lee MJ, Lee HS, Park SD, et al. Leonurus sibiricus herb
extract suppresses oxidative stress and ameliorates
hypercholesterolemia in C57BL/6 mice and TNF-alpha
induced expression of adhesion molecules and lectin-like
oxidized LDL receptor-1 in human umbilical vein
endothelial cells. Biosci Biotechnol Biochem 2010; 74: 279–
284.
39. Lacombe VA, Viatchenko-Karpinski S, Terentyev D, et al.
Mechanisms of impaired calcium handling underlying
subclinical diastolic dysfunction in diabetes. Am J Physiol
Regul Integr Comp Physiol 2007; 293: R1787–R1797.
40. Zhang L, Ward ML, Phillips AR, et al. Protection of the heart
by treatment with a divalent-copper-selective chelator
reveals a novel mechanism underlying cardiomyopathy in
diabetic rats. Cardiovasc Diabetol 2013; 12: 123.
41. Kohajda Z, Farkas-Morvay N, Jost N, et al. The effect of a
novel highly selective inhibitor of the sodium/calcium

http://wileyonlinelibrary.com/journal/jdi

42.

43.

44.

45.

46.

47.

48.

49.

50.

51.

exchanger (NCX) on cardiac arrhythmias in in vitro and
in vivo experiments. PLoS One 2016; 11: e0166041.
Howarth FC, Adem A, Adeghate EA, et al. Distribution of atrial
natriuretic peptide and its effects on contraction and
intracellular calcium in ventricular myocytes from
streptozotocin-induced diabetic rat. Peptides 2005; 26: 691–700.
Gilca GE, Stefanescu G, Badulescu O, et al. Diabetic
cardiomyopathy: current approach and potential diagnostic
and therapeutic targets. J Diabetes Res 2017; 2017: 1310265.
Bidasee KR, Nallani K, Yu Y, et al. Chronic diabetes increases
advanced glycation end products on cardiac ryanodine
receptors/calcium-release channels. Diabetes 2003; 52: 1825–
1836.
Naqvi RU, Macleod KT. Effect of hypertrophy on
mechanisms of relaxation in isolated cardiac myocytes from
guinea pig. Am J Physiol. 1994; 267(5 Pt 2): H1851–H1861.
Brooksby P, Levi AJ, Jones JV. Investigation of the
mechanisms underlying the increased contraction of
hypertrophied ventricular myocytes isolated from the
spontaneously hypertensive rat. Cardiovasc Res 1993; 27:
1268–1277.
Sipido KR, Volders PG, de Groot SH, et al. Enhanced Ca(2+)
release and Na/Ca exchange activity in hypertrophied
canine ventricular myocytes: potential link between
contractile adaptation and arrhythmogenesis. Circulation
2000; 102: 2137–2144.
Salem KA, Qureshi MA, Sydorenko V, et al. Effects of
exercise training on excitation-contraction coupling and
related mRNA expression in hearts of Goto-Kakizaki type 2
diabetic rats. Mol Cell Biochem 2013; 380: 83–96.
Currie S, Quinn FR, Sayeed RA, et al. Selective downregulation of sub-endocardial ryanodine receptor expression
in a rabbit model of left ventricular dysfunction. J Mol Cell
Cardiol 2005; 39: 309–317.
Igarashi-Saito K, Tsutsui H, Takahashi M, et al. Endocardial
versus epicardial differences of sarcoplasmic reticulum Ca2+ATPase gene expression in the canine failing myocardium.
Basic Res Cardiol 1999; 94: 267–273.
Xiong W, Tian Y, DiSilvestre D, et al. Transmural
heterogeneity of Na+-Ca2+ exchange: evidence for
differential expression in normal and failing hearts. Circ Res
2005; 97: 207–209.

SUPPORTING INFORMATION
Additional supporting information may be found online in the Supporting Information section at the end of the article.
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